Change - Announcement of Cessation::Resignation of an Independent Director

Issuer & Securities

Issuer/ Manager
HYPHENS PHARMA INTERNATIONAL LIMITED
Securities
HYPHENS PHARMA INTL LIMITED - SG1EE4000006 - 1J5
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
17-Apr-2020 17:54:24
Status
New
Announcement Sub Title
Resignation of an Independent Director
Announcement Reference
SG200417OTHR01CF
Submitted By (Co./ Ind. Name)
Lim See Wah
Designation
Executive Chairman & CEO
Description (Please provide a detailed description of the event in the box below)
Resignation of Dr Poon Thong Yuen as an Independent Director of the Company.

This announcement has been prepared by the Company and its contents have been reviewed by the Sponsor, DBS Bank Ltd. ("Sponsor") for compliance with the Singapore Exchange Securities Trading Limited ("SGX-ST") Listing Manual Section B: Rules of Catalist. The Sponsor has not verified the contents of this announcement.

This announcement has not been examined or approved by the SGX-ST. The SGX-ST assumes no responsibility for the contents of this announcement including the accuracy, completeness or correctness of any of the information, statements or opinions made or reports contained in this announcement.

The contact persons for the Sponsor are Ms Heng Mui Mui, Managing Director, and Mr Kelvin Wong, Senior Vice President, who can be contacted at 12 Marina Boulevard, Level 46, Marina Bay Financial Centre Tower 3, Singapore 018982, Telephone: +65 6878 8888.

Additional Details

Name Of Person
Poon Thong Yuen (Pan Dongyuan)
Age
45
Is effective date of cessation known?
Yes
If yes, please provide the date
08/05/2020
Detailed Reason (s) for cessation
Dr Poon Thong Yuen ("Dr Poon") has tendered his resignation as an Independent Director of the Company for personal matters and to dedicate more time to his other commitments.

Further, the Sponsor, after having interviewed Dr Poon, is satisfied that, other than as disclosed in this announcement, there are no material reasons for the resignation of Dr Poon as an Independent Director of the Company.

The Company expresses its gratitude to Dr Poon for his valuable contributions during his tenure of service.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of Appointment to current position
23/04/2018
Does the AC have a minimum of 3 members (taking into account this cessation)?
Yes
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
3
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
1
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Independent Director, Chairman of the Nominating Committee as well as member of the Audit Committee and Remuneration Committee.
Role and responsibilities
Duties as the Independent Director, Chairman of the Nominating Committee as well as member of the Audit Committee and Remuneration Committee.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
Nil
Shareholding interest in the listed issuer and its subsidiaries?
No
Past (for the last 5 years)
Singapore:
- Histoindex Pte. Ltd.
- ZIG Ventures Private Limited
- Amaranth Medical Pte. Ltd.
- Mirxes Pte. Ltd.

United States of America:
- Ivantis, Inc.
- Amaranth Medical, Inc.
- Inviragen, Inc.
- Sotera Wireless, Inc.

People's Republic of China:
- Choutu Technology Company Ltd
Present
Nil